10x Genomics, Inc. Quarterly Return On Assets in % from Q2 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
10x Genomics, Inc. quarterly/annual Return On Assets history and growth rate from Q2 2020 to Q3 2024.
  • 10x Genomics, Inc. Return On Assets for the quarter ending September 30, 2024 was -19.4 %, a 13.4% increase year-over-year.
  • 10x Genomics, Inc. annual Return On Assets for 2023 was -26.1 %, a 58.1% decline from 2022.
  • 10x Genomics, Inc. annual Return On Assets for 2022 was -16.5 %, a 179% decline from 2021.
  • 10x Genomics, Inc. annual Return On Assets for 2021 was -5.91 %, a 91.4% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -19.4 +3 +13.4% Jul 1, 2024 Sep 30, 2024
Q2 2024 -25.5 -8.36 -48.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 -27.6 -10.4 -60.1% Jan 1, 2024 Mar 31, 2024
Q4 2023 -26.1 -9.57 -58.1% Oct 1, 2023 Dec 31, 2023
Q3 2023 -22.4 -5.8 -34.9% Jul 1, 2023 Sep 30, 2023
Q2 2023 -17.1 -2.91 -20.5% Apr 1, 2023 Jun 30, 2023
Q1 2023 -17.3 -8.33 -93.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 -16.5 -10.6 -179% Oct 1, 2022 Dec 31, 2022
Q3 2022 -16.6 +30.7 +64.8% Jul 1, 2022 Sep 30, 2022
Q2 2022 -14.2 +37.5 +72.5% Apr 1, 2022 Jun 30, 2022
Q1 2022 -8.93 +51.9 +85.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 -5.91 +62.7 +91.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -47.3 -28.4 -150% Jul 1, 2021 Sep 30, 2021
Q2 2021 -51.7 -38.5 -292% Apr 1, 2021 Jun 30, 2021
Q1 2021 -60.8 Jan 1, 2021 Mar 31, 2021
Q4 2020 -68.6 Oct 1, 2020 Dec 31, 2020
Q3 2020 -18.9 Jul 1, 2020 Sep 30, 2020
Q2 2020 -13.2 Apr 1, 2020 Jun 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.